NCT01186653View on ClinicalTrials.gov

Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

budesonide / formoterol

budesonide / formoterol, 400 micrograms/9 micrograms one IH bd

DRUG

fluticasone/salmeterol

fluticasone/salmeterol, 250 micrograms/25 micrograms two puffs bd, dose as per NICE guidelines

Trial Locations (1)

HU16 5JQ

Respiratory Medicine, Castgle Hill Hospital, Cottingham

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT01186653 - Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter